Tom has helped U.S. and international businesses, issuers, and investment banks negotiate and close billions of dollars in cross-border financings, which includes multiple deals recognized as the "Deal of the Year" in their respective industries. For Tom, teamwork is the essential ingredient for success in complex deals.
Located in:
Areas of Focus:
Tom is an exceptionally experienced attorney who concentrates his practice on U.S. cross-border securities and corporate law matters. With a particular focus on U.S.-Canada activity, every year he and his team advise clients with respect to financing transactions totaling billions of dollars – regularly landing them among the top performers on Thomson Reuters' annual league tables and recently earning the "Pharmaceutical Deal of the Year" Atlas Award from Global M&A Network.
Tom's services adapt and grow along with the needs of his clients. He represents U.S. and foreign issuers and investment banks in a broad range of public and private financings, including financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS), other cross-border public offerings, and U.S.-foreign private placements (including Rule 144A, Regulation D, and Regulation S offerings). Tom also advises U.S. and foreign issuers with respect to the U.S. securities and corporate law aspects of mergers and acquisition transactions, including portfolio company roll-ups, as well as in connection with litigation arising from such deals.
Tom counsels U.S. and foreign issuers in connection with initial listings on the New York Stock Exchange (NYSE), the NYSE MKT, and the Nasdaq Stock Market (NASDAQ). He also helps clients ensure compliance with ongoing U.S. reporting and corporate governance requirements under U.S. federal securities laws and exchange rules, and acts as a principal American liaison (PAL) on the over-the-counter (OTC) international markets.
Tom has provided U.S. corporate and securities law advice for the following recent representative transactions/matters:
Life Sciences
Technology
Energy and Renewables
Mining
Underwriter/Agent Representations
Tom regularly acts for underwriters and agents on public and private offerings, including the following:
League Tables
Thompson Reuters/Refinitiv's Global Capital Markets Review - H1 2023
Canada Equity & Equity-Related (CAL4) Manager Legal Advisor
Canada Equity & Equity-Related (CAL4) Issuer Legal Advisor
Refinitiv Global Private Equity Legal Review - First Half 2023
Advisors to Company: LBO & Related Rounds Based on Number of Rounds
Advisors to Company: All Private Equity Stages Based on Number of Rounds
Bloomberg Global Legal Adviser
Canada Equity Offerings: Legal Adviser – Issuer Ranked by Deal Count
Canada Equity & Equity Linked: Legal Adviser – Issuer Ranked by Deal Count
Canada Equity, Equity Linked & Preferred: Legal Adviser – Issuer Ranked by Deal Count
Representative matters may include engagements before joining Troutman Pepper.
Tom is a frequent speaker on U.S. corporate and securities laws matters. His recent speaking engagements include, but are not limited to, the following:
Sponsored Events
04.16.24
2024 Bloom Burton & Co. Healthcare Investor Conference
Sponsored Events
03.19.24
CANADA - Cross Listing Discussion
Firm Events
03.17.24
The 36th Annual ROTH Conference
Speaking Engagements
03.14.24
IBA 7th Mergers and Acquisitions in the Technology Sector Conference
Firm News
02.02.24
Troutman Pepper's Canadian Practice Group Retains Top US Rankings in Industry League Tables for 10th Consecutive Year
Press Coverage
02.01.24
Biotech VCs Turn to Public Investments in Search of Value